Name | 2-amino-N,3,3-trimethylbutanamide |
---|---|
Synonyms |
2-azanyl-N,3,3-trimethyl-butanamide
(S)-2-AMINO-N,3,3-TRIMETHYLBUTANAMIDE Butanamide, 2-amino-N,3,3-trimethyl-, (2S)- 2S-amino-3,3,N-trimethyl-butyramide N,3-Dimethyl-L-valinamide (S)-3-methylvaline N-methylamide MFCD00673329 (2S)-2-Amino-3,3-dimethylbutanoic acid methylamide N1,3-dimethyl-L-valinamide L-tert-Leucine-N-methylamide (S)-2-amino-3,3,N-trimethyl-butyramide |
Description | S-tert-Leucine N-methylamide is a leucine derivative[1]. |
---|---|
Related Catalog | |
In Vitro | Amino acids and amino acid derivatives have been commercially used as ergogenic supplements. They influence the secretion of anabolic hormones, supply of fuel during exercise, mental performance during stress related tasks and prevent exercise induced muscle damage. They are recognized to be beneficial as ergogenic dietary substances[1]. |
References |
Density | 0.9±0.1 g/cm3 |
---|---|
Boiling Point | 266.8±23.0 °C at 760 mmHg |
Molecular Formula | C7H16N2O |
Molecular Weight | 144.215 |
Flash Point | 115.2±22.6 °C |
Exact Mass | 144.126266 |
PSA | 55.12000 |
LogP | -0.22 |
Vapour Pressure | 0.0±0.5 mmHg at 25°C |
Index of Refraction | 1.452 |
Hazard Codes | Xi |
---|---|
Risk Phrases | 36/37/38 |
Safety Phrases | 26-36/37/39 |
HS Code | 2924199090 |
~79% 89226-12-0 |
Literature: Glaxo Wellcome Inc. Patent: US6172064 B2, 2001 ; US 6172064 B1 |
~95% 89226-12-0 |
Literature: DSM N.V. Patent: US2001/41812 A1, 2001 ; |
~% 89226-12-0 |
Literature: US2001/41812 A1, ; |
~% 89226-12-0 |
Literature: Journal of Organic Chemistry, , vol. 70, # 26 p. 10792 - 10802 |
~% 89226-12-0 |
Literature: Organic Process Research and Development, , vol. 5, # 3 p. 294 - 298 |
Precursor 5 | |
---|---|
DownStream 1 | |
HS Code | 2924199090 |
---|---|
Summary | 2924199090. other acyclic amides (including acyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |